JPH0236235B2 - TATONSGG1NOSEIZOHOHO - Google Patents
TATONSGG1NOSEIZOHOHOInfo
- Publication number
- JPH0236235B2 JPH0236235B2 JP30522286A JP30522286A JPH0236235B2 JP H0236235 B2 JPH0236235 B2 JP H0236235B2 JP 30522286 A JP30522286 A JP 30522286A JP 30522286 A JP30522286 A JP 30522286A JP H0236235 B2 JPH0236235 B2 JP H0236235B2
- Authority
- JP
- Japan
- Prior art keywords
- polysaccharide
- nsg
- reaction
- bond
- range
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 150000004676 glycans Chemical class 0.000 claims description 52
- 229920001282 polysaccharide Polymers 0.000 claims description 52
- 239000005017 polysaccharide Substances 0.000 claims description 52
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 23
- 150000001720 carbohydrates Chemical class 0.000 claims description 18
- 239000000243 solution Substances 0.000 claims description 17
- 238000004519 manufacturing process Methods 0.000 claims description 14
- 238000006243 chemical reaction Methods 0.000 claims description 13
- 238000000034 method Methods 0.000 claims description 13
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 12
- 125000003535 D-glucopyranosyl group Chemical group [H]OC([H])([H])[C@@]1([H])OC([H])(*)[C@]([H])(O[H])[C@@]([H])(O[H])[C@]1([H])O[H] 0.000 claims description 11
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 claims description 9
- 235000019441 ethanol Nutrition 0.000 claims description 9
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 claims description 8
- 241000221662 Sclerotinia Species 0.000 claims description 7
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 claims description 6
- 241000221696 Sclerotinia sclerotiorum Species 0.000 claims description 6
- 229910052799 carbon Inorganic materials 0.000 claims description 6
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 claims description 5
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 claims description 4
- 125000005640 glucopyranosyl group Chemical group 0.000 claims description 4
- 230000007935 neutral effect Effects 0.000 claims description 4
- 238000000862 absorption spectrum Methods 0.000 claims description 3
- 230000002378 acidificating effect Effects 0.000 claims description 3
- 239000007864 aqueous solution Substances 0.000 claims description 3
- 230000001580 bacterial effect Effects 0.000 claims description 3
- 238000001460 carbon-13 nuclear magnetic resonance spectrum Methods 0.000 claims description 3
- OQUKIQWCVTZJAF-UHFFFAOYSA-N phenol;sulfuric acid Chemical compound OS(O)(=O)=O.OC1=CC=CC=C1 OQUKIQWCVTZJAF-UHFFFAOYSA-N 0.000 claims description 3
- MYKOKMFESWKQRX-UHFFFAOYSA-N 10h-anthracen-9-one;sulfuric acid Chemical compound OS(O)(=O)=O.C1=CC=C2C(=O)C3=CC=CC=C3CC2=C1 MYKOKMFESWKQRX-UHFFFAOYSA-N 0.000 claims description 2
- 238000010521 absorption reaction Methods 0.000 claims description 2
- 239000003513 alkali Substances 0.000 claims description 2
- 238000000921 elemental analysis Methods 0.000 claims description 2
- 238000002844 melting Methods 0.000 claims description 2
- 230000008018 melting Effects 0.000 claims description 2
- FEMOMIGRRWSMCU-UHFFFAOYSA-N ninhydrin Chemical compound C1=CC=C2C(=O)C(O)(O)C(=O)C2=C1 FEMOMIGRRWSMCU-UHFFFAOYSA-N 0.000 claims description 2
- 239000003960 organic solvent Substances 0.000 claims description 2
- 238000011002 quantification Methods 0.000 claims description 2
- 238000002523 gelfiltration Methods 0.000 claims 1
- 238000005979 thermal decomposition reaction Methods 0.000 claims 1
- 235000014633 carbohydrates Nutrition 0.000 description 17
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 16
- 239000008103 glucose Substances 0.000 description 16
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 12
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 11
- 235000000346 sugar Nutrition 0.000 description 11
- 230000000259 anti-tumor effect Effects 0.000 description 9
- 241001138406 Sclerotiniaceae Species 0.000 description 7
- 239000002244 precipitate Substances 0.000 description 7
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 6
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 6
- 239000002609 medium Substances 0.000 description 6
- 238000012360 testing method Methods 0.000 description 6
- 239000002054 inoculum Substances 0.000 description 5
- 239000000203 mixture Substances 0.000 description 5
- FYGDTMLNYKFZSV-URKRLVJHSA-N (2s,3r,4s,5s,6r)-2-[(2r,4r,5r,6s)-4,5-dihydroxy-2-(hydroxymethyl)-6-[(2r,4r,5r,6s)-4,5,6-trihydroxy-2-(hydroxymethyl)oxan-3-yl]oxyoxan-3-yl]oxy-6-(hydroxymethyl)oxane-3,4,5-triol Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1[C@@H](CO)O[C@@H](OC2[C@H](O[C@H](O)[C@H](O)[C@H]2O)CO)[C@H](O)[C@H]1O FYGDTMLNYKFZSV-URKRLVJHSA-N 0.000 description 4
- SRBFZHDQGSBBOR-IOVATXLUSA-N D-xylopyranose Chemical compound O[C@@H]1COC(O)[C@H](O)[C@H]1O SRBFZHDQGSBBOR-IOVATXLUSA-N 0.000 description 4
- 206010028980 Neoplasm Diseases 0.000 description 4
- 229930006000 Sucrose Natural products 0.000 description 4
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 4
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 4
- 229910052757 nitrogen Inorganic materials 0.000 description 4
- 239000000047 product Substances 0.000 description 4
- 239000005720 sucrose Substances 0.000 description 4
- 241000235349 Ascomycota Species 0.000 description 3
- 229920002498 Beta-glucan Polymers 0.000 description 3
- 229930091371 Fructose Natural products 0.000 description 3
- 239000005715 Fructose Substances 0.000 description 3
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 3
- 241000576755 Sclerotia Species 0.000 description 3
- 239000002253 acid Substances 0.000 description 3
- 238000005273 aeration Methods 0.000 description 3
- 238000004458 analytical method Methods 0.000 description 3
- PYMYPHUHKUWMLA-UHFFFAOYSA-N arabinose Natural products OCC(O)C(O)C(O)C=O PYMYPHUHKUWMLA-UHFFFAOYSA-N 0.000 description 3
- SRBFZHDQGSBBOR-UHFFFAOYSA-N beta-D-Pyranose-Lyxose Natural products OC1COC(O)C(O)C1O SRBFZHDQGSBBOR-UHFFFAOYSA-N 0.000 description 3
- 229940041514 candida albicans extract Drugs 0.000 description 3
- 239000000470 constituent Substances 0.000 description 3
- 238000012258 culturing Methods 0.000 description 3
- 238000000354 decomposition reaction Methods 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 235000011187 glycerol Nutrition 0.000 description 3
- 238000000746 purification Methods 0.000 description 3
- 238000003756 stirring Methods 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- 150000008163 sugars Chemical class 0.000 description 3
- 239000012138 yeast extract Substances 0.000 description 3
- WQZGKKKJIJFFOK-QTVWNMPRSA-N D-mannopyranose Chemical compound OC[C@H]1OC(O)[C@@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-QTVWNMPRSA-N 0.000 description 2
- 241000233866 Fungi Species 0.000 description 2
- 229920001503 Glucan Polymers 0.000 description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 2
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 2
- 241001465754 Metazoa Species 0.000 description 2
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 2
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 2
- MUPFEKGTMRGPLJ-RMMQSMQOSA-N Raffinose Natural products O(C[C@H]1[C@@H](O)[C@H](O)[C@@H](O)[C@@H](O[C@@]2(CO)[C@H](O)[C@@H](O)[C@@H](CO)O2)O1)[C@@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 MUPFEKGTMRGPLJ-RMMQSMQOSA-N 0.000 description 2
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 2
- DTQVDTLACAAQTR-UHFFFAOYSA-N Trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F DTQVDTLACAAQTR-UHFFFAOYSA-N 0.000 description 2
- MUPFEKGTMRGPLJ-UHFFFAOYSA-N UNPD196149 Natural products OC1C(O)C(CO)OC1(CO)OC1C(O)C(O)C(O)C(COC2C(C(O)C(O)C(CO)O2)O)O1 MUPFEKGTMRGPLJ-UHFFFAOYSA-N 0.000 description 2
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 2
- 150000007513 acids Chemical class 0.000 description 2
- WQZGKKKJIJFFOK-PHYPRBDBSA-N alpha-D-galactose Chemical compound OC[C@H]1O[C@H](O)[C@H](O)[C@@H](O)[C@H]1O WQZGKKKJIJFFOK-PHYPRBDBSA-N 0.000 description 2
- 239000000306 component Substances 0.000 description 2
- 238000001816 cooling Methods 0.000 description 2
- 230000007423 decrease Effects 0.000 description 2
- 238000001514 detection method Methods 0.000 description 2
- 239000000706 filtrate Substances 0.000 description 2
- 229930182830 galactose Natural products 0.000 description 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 239000011777 magnesium Substances 0.000 description 2
- 229910052749 magnesium Inorganic materials 0.000 description 2
- 244000005700 microbiome Species 0.000 description 2
- 230000000144 pharmacologic effect Effects 0.000 description 2
- 229910052698 phosphorus Inorganic materials 0.000 description 2
- 239000011574 phosphorus Substances 0.000 description 2
- 239000002504 physiological saline solution Substances 0.000 description 2
- 239000011591 potassium Substances 0.000 description 2
- 229910052700 potassium Inorganic materials 0.000 description 2
- 238000012545 processing Methods 0.000 description 2
- MUPFEKGTMRGPLJ-ZQSKZDJDSA-N raffinose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO[C@@H]2[C@@H]([C@@H](O)[C@@H](O)[C@@H](CO)O2)O)O1 MUPFEKGTMRGPLJ-ZQSKZDJDSA-N 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 238000002054 transplantation Methods 0.000 description 2
- OWEGMIWEEQEYGQ-UHFFFAOYSA-N 100676-05-9 Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC2C(OC(O)C(O)C2O)CO)O1 OWEGMIWEEQEYGQ-UHFFFAOYSA-N 0.000 description 1
- FEBUJFMRSBAMES-UHFFFAOYSA-N 2-[(2-{[3,5-dihydroxy-2-(hydroxymethyl)-6-phosphanyloxan-4-yl]oxy}-3,5-dihydroxy-6-({[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}methyl)oxan-4-yl)oxy]-3,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl phosphinite Chemical compound OC1C(O)C(O)C(CO)OC1OCC1C(O)C(OC2C(C(OP)C(O)C(CO)O2)O)C(O)C(OC2C(C(CO)OC(P)C2O)O)O1 FEBUJFMRSBAMES-UHFFFAOYSA-N 0.000 description 1
- 244000215068 Acacia senegal Species 0.000 description 1
- 229920001817 Agar Polymers 0.000 description 1
- 235000001674 Agaricus brunnescens Nutrition 0.000 description 1
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 241000219310 Beta vulgaris subsp. vulgaris Species 0.000 description 1
- 241000219193 Brassicaceae Species 0.000 description 1
- 206010006187 Breast cancer Diseases 0.000 description 1
- 208000026310 Breast neoplasm Diseases 0.000 description 1
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 1
- SHZGCJCMOBCMKK-UHFFFAOYSA-N D-mannomethylose Natural products CC1OC(O)C(O)C(O)C1O SHZGCJCMOBCMKK-UHFFFAOYSA-N 0.000 description 1
- 239000004375 Dextrin Substances 0.000 description 1
- 229920001353 Dextrin Polymers 0.000 description 1
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 description 1
- IAZDPXIOMUYVGZ-WFGJKAKNSA-N Dimethyl sulfoxide Chemical compound [2H]C([2H])([2H])S(=O)C([2H])([2H])[2H] IAZDPXIOMUYVGZ-WFGJKAKNSA-N 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 229920002444 Exopolysaccharide Polymers 0.000 description 1
- 201000008808 Fibrosarcoma Diseases 0.000 description 1
- PNNNRSAQSRJVSB-SLPGGIOYSA-N Fucose Natural products C[C@H](O)[C@@H](O)[C@H](O)[C@H](O)C=O PNNNRSAQSRJVSB-SLPGGIOYSA-N 0.000 description 1
- 102100035695 Gamma-aminobutyric acid receptor-associated protein Human genes 0.000 description 1
- 229920000084 Gum arabic Polymers 0.000 description 1
- 241000221661 Helotiales Species 0.000 description 1
- 101001001372 Homo sapiens Gamma-aminobutyric acid receptor-associated protein Proteins 0.000 description 1
- 244000017020 Ipomoea batatas Species 0.000 description 1
- 235000002678 Ipomoea batatas Nutrition 0.000 description 1
- SHZGCJCMOBCMKK-DHVFOXMCSA-N L-fucopyranose Chemical compound C[C@@H]1OC(O)[C@@H](O)[C@H](O)[C@@H]1O SHZGCJCMOBCMKK-DHVFOXMCSA-N 0.000 description 1
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 1
- GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 description 1
- 229930195725 Mannitol Natural products 0.000 description 1
- 239000004677 Nylon Substances 0.000 description 1
- 108010009736 Protein Hydrolysates Proteins 0.000 description 1
- 208000006268 Sarcoma 180 Diseases 0.000 description 1
- 229920002305 Schizophyllan Polymers 0.000 description 1
- 229920002684 Sepharose Polymers 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 235000021536 Sugar beet Nutrition 0.000 description 1
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 1
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 description 1
- 239000000205 acacia gum Substances 0.000 description 1
- 235000010489 acacia gum Nutrition 0.000 description 1
- 239000008272 agar Substances 0.000 description 1
- -1 alditol acetate derivative Chemical class 0.000 description 1
- PYMYPHUHKUWMLA-WDCZJNDASA-N arabinose Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)C=O PYMYPHUHKUWMLA-WDCZJNDASA-N 0.000 description 1
- GUBGYTABKSRVRQ-QUYVBRFLSA-N beta-maltose Chemical compound OC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O)[C@H](O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@@H]1O GUBGYTABKSRVRQ-QUYVBRFLSA-N 0.000 description 1
- DLRVVLDZNNYCBX-ZZFZYMBESA-N beta-melibiose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@@H]1OC[C@@H]1[C@@H](O)[C@H](O)[C@@H](O)[C@H](O)O1 DLRVVLDZNNYCBX-ZZFZYMBESA-N 0.000 description 1
- 239000007853 buffer solution Substances 0.000 description 1
- 230000003139 buffering effect Effects 0.000 description 1
- 239000004202 carbamide Substances 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 239000003086 colorant Substances 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 235000019425 dextrin Nutrition 0.000 description 1
- 239000000385 dialysis solution Substances 0.000 description 1
- 239000002552 dosage form Substances 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 238000004817 gas chromatography Methods 0.000 description 1
- 238000001641 gel filtration chromatography Methods 0.000 description 1
- 125000002791 glucosyl group Chemical group C1([C@H](O)[C@@H](O)[C@H](O)[C@H](O1)CO)* 0.000 description 1
- 210000004013 groin Anatomy 0.000 description 1
- 229910052736 halogen Inorganic materials 0.000 description 1
- 150000002367 halogens Chemical class 0.000 description 1
- 229910052739 hydrogen Inorganic materials 0.000 description 1
- 238000011534 incubation Methods 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 238000007912 intraperitoneal administration Methods 0.000 description 1
- 230000002601 intratumoral effect Effects 0.000 description 1
- 238000001990 intravenous administration Methods 0.000 description 1
- 239000004310 lactic acid Substances 0.000 description 1
- 235000014655 lactic acid Nutrition 0.000 description 1
- 239000008101 lactose Substances 0.000 description 1
- 239000000594 mannitol Substances 0.000 description 1
- 235000010355 mannitol Nutrition 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 239000012533 medium component Substances 0.000 description 1
- 230000011987 methylation Effects 0.000 description 1
- 238000007069 methylation reaction Methods 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 235000013379 molasses Nutrition 0.000 description 1
- 125000000896 monocarboxylic acid group Chemical group 0.000 description 1
- 150000002772 monosaccharides Chemical class 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 229920001778 nylon Polymers 0.000 description 1
- 229920001542 oligosaccharide Polymers 0.000 description 1
- 150000002482 oligosaccharides Chemical class 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 235000005985 organic acids Nutrition 0.000 description 1
- 238000010979 pH adjustment Methods 0.000 description 1
- 230000000704 physical effect Effects 0.000 description 1
- 229920001223 polyethylene glycol Polymers 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 238000004321 preservation Methods 0.000 description 1
- 108090000765 processed proteins & peptides Proteins 0.000 description 1
- 102000004196 processed proteins & peptides Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 230000000717 retained effect Effects 0.000 description 1
- 238000012552 review Methods 0.000 description 1
- 229910000033 sodium borohydride Inorganic materials 0.000 description 1
- 239000012279 sodium borohydride Substances 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 239000012879 subculture medium Substances 0.000 description 1
- 150000005846 sugar alcohols Polymers 0.000 description 1
- 229910052717 sulfur Inorganic materials 0.000 description 1
- 239000011593 sulfur Substances 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 235000002906 tartaric acid Nutrition 0.000 description 1
- 239000011975 tartaric acid Substances 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- 150000004043 trisaccharides Chemical class 0.000 description 1
- 210000004881 tumor cell Anatomy 0.000 description 1
- 238000002525 ultrasonication Methods 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
Description
(産業上の利用分野)
本発明に多糖NSG―1を製造する方法に関す
るものである。
更に詳細には、本発明は抗腫瘍活性を有する多
糖NSG―1を製造する方法に関するものである。
本発明では、インキユベーシヨンによつて糖質
から直接多糖NSG―1を生合成するために、き
わめて純度の高い抗腫瘍活性多糖NSG―1を多
量生産することができ、医薬界に貢献するところ
大なるものがある。
(従来の技術)
キツネノワンタケ科(Sclerotiniaceae)に属
するきのこ菌がアブラナ科の植物の根や茎に形成
する菌核中にβ―(1→3)結合するD―グルコ
ピラノシル残基を骨格とし、この骨格3ケごとに
C―6に結合する1ケのD―グルコピラノシル残
基を有する多糖が含まれていることが知られてお
り(北原等岐阜大学農学部研究報告8100(1957)、
9139(1958)、日本農芸化学会誌35468(1961)、更
に上記きのこ菌を液体培養すると培養液中に北原
等の見い出した構造の多糖と同様の多糖が産生す
ることをUENO等スクレロチニア リベルチア
ナ(Sclerotinia libertiana)菌糸を(Agric.
Boil.Chem.,44(2)、353〜359、1980)がシユク
ロース、NaNO3、MgSO4・7H2O、KH2PO4、
イーストエキスを含む培地中で中で24〜25℃で数
日間振盪培養した後の粘稠な培養液からメタノー
ル沈でん法によつて得ている。
上記多糖は通常スクレログルカンと称され(糖
質の化学上P95東京化学同人1986、7、1発行)
抗腫瘍活性を有している(フアルマシアレビユー
No.6P121日本薬学会)。
(発明が解決しようとする問題点)
上記菌核や培養液から多糖を分離採取する従来
の方法にあつては、菌核自体や培養液から移行す
る各種成分の除去に多くの煩雑な精製手段を要
し、実用面において解決されなければならない問
題が多く残されている。
(問題点を解決するための手段)
この発明者らは、上記有用な多糖を容易に入手
する方法について鋭意研究した結果、キツネノワ
ンタケ科(Sclerotiniaceae)に属する機関保存
菌株であるスクレロチニア スクレロチオリウム
(Sclerotinia solerotiorum)IFO9395の培養菌糸
を窒素源、リン、カリ、マグネシウム等の通常微
生物の培養に必要な栄養成分を欠き、PHを酸性領
域とした糖質溶液に添加し、上記菌糸を糖質に酵
素的に作用させると溶液中に多量の多糖NSG―
1を生成することを知り、菌糸を除いた溶液にア
ルコールを加えるのみで殆んど純粋な多糖NSG
―1を得ることができたものであり、動物試験に
より抗腫瘍活性を確認でき、物理化学的試験によ
り、多糖NSG―1の構造が、前記スクレロチニ
ア リベルチアナの培養液から得られているβ―
(1→3)結合するD―グルコピラノシル残基3
ケごとに1ケのD―グルコピラノシル残基1ケの
分枝構造の多糖とはその構造を異にし、β―(1
→3)結合するD―グルコピラノシル残基2ケご
とにC―6に1ケのD―グルコピラノシル残基1
ケの分枝を有する構造の多糖であることが確認で
きた。
多糖NSG―1の生成に用いるキツネノワンタ
ケ科(Sclerotiniaceae)に属する菌株は、今関
六也、本郷次朗共著「原色日本菌類図鑑」(保育
社昭和54年発行)により子のう菌類
(Ascomycetes)、びようたけ目(Helotiales)、
キツネノワンタケ科(Sclerotiniaceae)に分類
され、同図鑑記載の特性を有するものであり、天
然から分離して純化、継代培養によりその形質を
保持しているもの或いは各種保存機関に在る保存
菌株等この発明の方法によつて、多糖NSG―1
を生成する能力を有する菌株である。
この発明は、前記のようにキツネノワンタケ科
(Sclerotiniaceae)に属するNSG―1生産性スク
レロチニア(Sclerotinia)属菌株の菌糸をグル
コース等の糖質に酵素的に作用させることによつ
て多糖NSG―1を生成せしめ、これを分離採取
することを特徴とするものであるが、キツネノワ
ンタケ科(Sclerotiniaceae)に属する菌株を用
いてかかる手法で多糖を生成せしめることは従来
知られていない。
いま、この発明に用いることができるキツネノ
ワンタケ科(Sclerotiniaceae)に属する菌株の
代表例として良好に多糖NSG―1の生成をもた
らしたスクレロチニア(Sclerotinia)属の保存
菌株であるスクレロチニア スクレロチオリウム
(Sclerotinia Sclerotiorum)IFO9395による多糖
NSG―1について説明する。
スクレロチニア スクレロチオリウム
(Sclerotinia sclerotiorum)IFO9395の保存斜面
から菌糸体を含む寒天培地切片(5×5×2mm)
2片を例えばイーストエキス0.3%、ベプトン1
%、グルコース2%を含む培地100mlに接種して
28℃で4日間振盪培養し、培養物を遠心分離して
菌糸体を分別する。この菌糸体を十分に洗浄して
培地成分を除去した後、再度遠心分離してこの全
量をフラスコに移し水を加えて全量400mlとなし、
均一な懸濁液の40ml宛を別に用意するグルコース
5g、クエン酸、0.5gを含み予めPHを2.5〜6.0の
試験値に調整(NaOHによる)した糖質液60ml
宛を分注するフラスコ8本に夫々注加し、28℃で
4日間振盪又は撹拌下で保持せしめると、第1表
に示すように各調整PHに対応して溶液中に多糖を
生成する。
すなわち、28℃で4日間保持した後、内容物を
夫々遠心分離により菌糸体を分離液とに分別し、
分離液にエタノール50ml宛を添加すると沈でん物
を生成する。この沈でん物をエタノールで洗浄
後、真空乾燥すると白色綿状の物質を得る。
上記で得た白色綿状の物質は後述するようにグ
ルコースのみを構成糖とするβ―グルカンで、抗
腫瘍活性を有する多糖NSG―1(以下、多糖と略
することが多い)である。
(Industrial Application Field) The present invention relates to a method for producing polysaccharide NSG-1. More specifically, the present invention relates to a method for producing polysaccharide NSG-1 having antitumor activity. In the present invention, polysaccharide NSG-1 is biosynthesized directly from carbohydrates by incubation, so it is possible to produce a large amount of extremely pure anti-tumor active polysaccharide NSG-1, thereby contributing to the medical world. There is something big here. (Prior technology) Mushroom fungi belonging to the Sclerotiniaceae family have a skeleton of D-glucopyranosyl residues with β-(1→3) bonds in the sclerotia formed on the roots and stems of plants of the Brassicaceae family. It is known that polysaccharides with one D-glucopyranosyl residue bonded to C-6 for every three residues are included (Kitahara et al. Gifu University Faculty of Agriculture Research Report 8100 (1957),
9139 (1958), Journal of the Japanese Society of Agricultural Chemistry 35468 (1961), and UENO etc. Sclerotinia libertiana (Sclerotinia libertiana). ) Hyphae (Agric.)
Boil.Chem., 44(2), 353-359, 1980) is sucrose, NaNO 3 , MgSO 4 .7H 2 O, KH 2 PO 4 ,
It is obtained by the methanol precipitation method from the viscous culture solution obtained after shaking culture at 24-25°C for several days in a medium containing yeast extract. The above polysaccharide is usually called scleroglucan (on the chemistry of carbohydrates, P95, published by Tokyo Kagaku Doujin 1986, 7, 1).
It has antitumor activity (Pharmacia Review)
No.6P121 Pharmaceutical Society of Japan). (Problems to be Solved by the Invention) In the conventional method of separating and collecting polysaccharides from the sclerotia and the culture solution, many complicated purification methods are required to remove various components transferred from the sclerotia themselves and the culture solution. However, many problems remain to be solved in practical terms. (Means for Solving the Problems) As a result of intensive research on how to easily obtain the above-mentioned useful polysaccharides, the inventors discovered that Sclerotinia sclerothiolium, an institutionally preserved strain belonging to the family Sclerotiniaceae, Cultured mycelia of Sclerotinia solerotiorum) IFO9395 were added to a carbohydrate solution lacking nitrogen sources, nutrients necessary for the cultivation of normal microorganisms such as phosphorus, potassium, and magnesium, and whose pH was in the acidic range. When exposed to water, a large amount of polysaccharide NSG appears in the solution.
Knowing that 1 is produced, almost pure polysaccharide NSG can be produced by simply adding alcohol to the solution after removing the hyphae.
The antitumor activity was confirmed in animal tests, and the structure of polysaccharide NSG-1 was confirmed by physicochemical tests.
(1 → 3) Bound D-glucopyranosyl residue 3
Its structure is different from that of the polysaccharide, which has a branched structure of one D-glucopyranosyl residue and one D-glucopyranosyl residue for each
→3) 1 D-glucopyranosyl residue 1 at C-6 for every 2 D-glucopyranosyl residues bonded
It was confirmed that the polysaccharide has a structure with 5 branches. Bacterial strains belonging to the Sclerotiniaceae family used to produce the polysaccharide NSG-1 are classified as Ascomycetes, Ascomycetes, and Ascomycetes, according to the "Illustrated Encyclopedia of Primary Colors of Japanese Fungi" co-authored by Mutsuya Imazeki and Jiro Hongo (published by Yokusha in 1978). Takeme (Helotiales),
It is classified into the family Sclerotiniaceae and has the characteristics described in the same encyclopedia.It is isolated from nature and has retained its characteristics through purification and subculturing, or preserved strains in various preservation institutions, etc. By the method of the invention, polysaccharide NSG-1
It is a strain that has the ability to produce. As described above, this invention produces polysaccharide NSG-1 by enzymatically acting on carbohydrates such as glucose with the hyphae of an NSG-1-producing Sclerotinia strain belonging to the Sclerotiniaceae family. However, it has not been known to date that polysaccharides can be produced by such a method using bacterial strains belonging to the Sclerotiniaceae family. Now, as a representative example of a strain belonging to the Sclerotiniaceae family that can be used in this invention, a conserved strain of the genus Sclerotinia that has successfully produced the polysaccharide NSG-1 is Sclerotinia Sclerotiorum. ) Polysaccharide by IFO9395
Let me explain about NSG-1. Agar medium section (5 x 5 x 2 mm) containing mycelium from a preserved slope of Sclerotinia sclerotiorum IFO9395
For example, add 2 pieces of yeast extract 0.3%, Beptone 1
%, inoculated into 100 ml of medium containing 2% glucose.
Culture with shaking at 28°C for 4 days, and centrifuge the culture to separate mycelia. After thoroughly washing the mycelium to remove medium components, centrifuge it again, transfer the entire volume to a flask, and add water to make a total volume of 400 ml.
Separately prepare 40 ml of a homogeneous suspension. 60 ml of a carbohydrate solution containing 5 g of glucose, 0.5 g of citric acid, and whose pH has been adjusted to a test value of 2.5 to 6.0 (by NaOH).
When the solution is poured into 8 flasks and kept at 28°C for 4 days with shaking or stirring, polysaccharides are produced in the solution corresponding to each adjusted pH as shown in Table 1. That is, after holding at 28°C for 4 days, the contents were centrifuged to separate the mycelium and the separated liquid,
Adding 50 ml of ethanol to the separated solution will produce a precipitate. This precipitate is washed with ethanol and then vacuum dried to obtain a white flocculent material. As will be described later, the white flocculent substance obtained above is a polysaccharide NSG-1 (hereinafter often abbreviated as polysaccharide), which is β-glucan whose constituent sugar is glucose only, and which has antitumor activity.
【表】
第1表から初発PHを2.5〜6.0とした場合、生成
量の多僅はあるがいずれの場合にも多糖の生成が
認められ、初発PHを3.0〜4.5とするとき生成量が
顕著であり、特に3.4〜4.5の範囲が好ましいこと
を認める。
この発明は、上記のように通常、微生物の培養
に不可欠な窒素源やリン、カリ、マグネシウム等
無機成分を含まず、糖質としてグルコースのみを
含み、他にはPH調整のための僅少のクエン酸と
NaOHを含む糖質溶液に菌糸体を添加してグル
コースから多糖を生成せしめたものであるから、
培養による菌体外多糖産生とは明らかに生成機構
を異にするもので、菌糸体が糖質として用いたグ
ルコースに酵素的に作用したものと認めることが
できる。
かように、この発明においてはスクレロチニア
(Sclerotinia)属に属する菌を培養して得る菌糸
体を糖質に酵素的に作用せしめるものであり、糖
質としては、上記グルコースの他に各種糖類が使
用でき、例えば、アラビノース、キシロース、フ
ラクトース、マンノース、ガラクトース、マルト
ース、シユクロース、メリビオース、ラクトー
ス、ラフイノース等の単糖類ないし三糖類、フラ
クトオリゴ或はガラクトオリゴ等に代表される各
種オリゴ糖、デンプン、デキストリン、アラビア
ゴム等の高分子物質及びこれらの加水分解物、そ
の他グリセリン、マニトールのような多価アルコ
ール、或は用途によつてはシユクロース、グルコ
ース、フラクトース、ラフイノース等を含有する
甘藷或は甜菜糖密を挙げることができるが、好ま
しくはグルコース、フラクトース、シユクロース
等を使用するのがよい、また上に挙げた糖質は
夫々単独又は2種以上の混合で用いてよい。
糖質溶液の初発PHの調整には、通常クエン酸、
酒石酸、乳酸のような緩衝性の強い有機酸を用い
るが、塩酸、硫酸等の鉱酸のほか、緩衝液も使用
できる。更に第1表に見られるように時間の経過
につれてPH低下が認められるので、初発PH維持の
ため、中途において上記酸類によりPH調整を行つ
てもよい。
糖質と菌糸体の振盪又は撹拌による両者接触は
20〜30℃の範囲で2〜8日行うが、28±1℃、3
±1日がより好ましい。
尚、スクレロチニア(Sclerotinia)属に属す
る菌株の菌糸体は、培養後分離してただちに用い
ても、一旦凍結貯蔵したものを使用の都度解凍使
用してもよい。更に一度多糖生成に供した使用済
の菌糸体を新たに調製した糖質溶液に添加し多糖
生成に供することもでき、反復使用により糖質生
成量は若干減ずるが、少なくとも同一菌糸体を3
回の多糖生成に使用可能である。
次に、第1表において初発PH3.5にて得た多糖
NSG―1の組成及び糖構造について分析した結
果は次のとおりである。
(1) 組成分析、
全糖分 全窒素 灰分
95%以上 検出限度以下 検出限度以下
但し全糖分は、フエノール硫酸法により定量
し、グルコースとして示したもである。
(2) 構成糖、
三弗化酢酸(CF3COOH)による加水分解物
を水素化ホウ素ナトリウム(NaBH4)で還元
し、これのアルジトールアセテート誘導体をガ
スクロマトグラフイー分析した結果、グルコー
スのみを明確に検出し、フコース、キシロー
ス、マンノース、ガラクトース等の他の糖は検
出しない。
(3) 構成糖の結合様式
箱守法によるメチル化分析の結果は2,3,
4,6―テトラメチル―O―D―グリシトー
ル:2,4,6―トリメチル―O―D―グリシ
トール:2,4―ジメチル―O―D―グリシト
ールが1.0:0.9〜1.1:0.9〜1.1の比で得られる
ことから1→3結合D―グルコピラノシル残基
2個ごとに1→6結合D―グルコピラノシル残
基1ケの分枝を有するグルカンであることが知
られる。
(4) スミス分解生成物
完全スミス分解により、生成物としてグルコ
ースとグリセリンを検出し、緩和スミス分解物
の透析外液からグリセリンをそして内液の加水
分解液からグルコースのみを検出したことか
ら、1→3結合とC―6に分枝を有する構造の
グルカンであることが知られる。
(5) 赤外線吸収スペクトル
日立215型赤外線分光々度計を用いKBr法で
測定した結果は第1図のとおりで、波数880cm
-1にβ―グリコシド結合配向に特徴的な吸収
(P)を認めることから、β―グリコシド結合
構造であることが認められる。
(6) 13C―NMRスペクトル
重ジメチルスルフオキシド(DMSC―d6)に
溶解し、JEOL―FX200スペクトルメーターに
より60℃で測定した結果は第2図のとおりで、
δ値68ppm域のβ(1→6)結合に含まれるC
―6の炭素の帰属を含むシグナルS1と、δ値
86ppm域のβ(1→3)結合に含まれるC―3
の炭素に帰属するシグナルS2と、δ値103ppm
域のβ―結合のC―1の炭素に帰属するシグナ
ルS3が特徴的に認められ、更にシグナルS2が2
つのピークを示すことから、β(1→3)結合
が2個あり、β(1→6)が1個あるβ―グル
カン構造が知られる。
以上の検討結果から、この多糖はβ―1,3結
合のD―グルコピラノシル残基を主鎖としこのD
―グルコピラノシル残基2ケごとにβ―1,6結
合のグルコピラノシル残基1ケを分枝構造として
持つβ―グルカンであると認められ、以下の諸性
質を示す。
(イ) 元素分析値等
C:42.2〜44.0%、H:5.9〜6.2%、N:定
量限界以下、ハロゲン、硫黄は定量されない。
(ロ) 分子量
0.2モルNaOH/8モル尿素平衡セフアロー
スCL―4B(フアーマシア・ジヤパン)カラム
によるゲル濾過クロマトグラフイーにより分子
量の分布範囲が106〜107である。
(ハ) 融点
約230℃で黒色化熱分解する。
(ニ) 比旋光度
20℃における水中濃度0.1g/100mlの〔α〕D
が10±5゜を示す。
(ホ) 溶解性
水、アルカリ、ジメチルスルフオキシド
(DMSO)に易溶、エチルアルコール、メチル
アルコール、エーテル、アセトン等の有機溶媒
には不溶である。
(ヘ) 呈色反応
モーリツシユ反応、アンスロン硫酸反応、フ
エノール硫酸反応はいずれも陽性を呈し、ニン
ヒドリン反応、ビユーレツト反応が共に陰性で
あることから蛋白質、ペプチドの存在を示さな
い。
(ト) 水溶性の塩基性、酸性、中性の別
1%水溶液は中性域(PH6〜6.5)を示す。
この発明の方法で得る多糖は、上記した物理、
化学的諸性質を有するβ―グルカンで後述のよう
に抗腫瘍活性を示すことから、薬用として有用
で、かつ製法自体も極めて簡単であるから、この
発明によるときは、抗腫瘍活性多糖を安価に提供
するものであり、この多糖は腹腔内投与、静脈内
投与、腫瘍内投与及び経口投与として使用できる
ほか、各種態様での使用が期待できるものであ
る。以下この発明の製造方法とこれにより得る多
糖の薬理作用について具体的に説明する。
実施例 1
スクレロチニア スクレロチオリウム
(Sclerotinia sclerotiorum)IFO9395の継代培地
より5×5×2mmの切片2ケをイーストエキス
0.3%、ポリペプトン1%、グルコース2%を含
みオートクレーブ処理した培地50mlに接種した25
℃、1週間静置培養してこれを1次種菌とする。
次いで上記と同じ組成のオートクレーブ処理培地
100mlに一次種菌5mlを接種し、25℃、4日間振
盪培養してこれを二次種菌とする、次いで上記と
同じ組成の培地6を10容量のジヤーフアーメ
ンターに採り、これに上記二次種菌の2本分
(200ml)を加え、通気量3/min、28℃で3日
間培養して、培養液100ml当り、菌糸体乾物重量
423.2mgの培養物を得た。この内容物の全量を濾
紙(No.2)にて吸引濾過し水で十分に洗浄した
後、除水してこの全量を、10容量のジヤーフア
ーメンターに収容したグルコース5%、クエン酸
0.5%を含み5N―NaOHにてPH3.5に調整した糖質
溶液6に加え、通気量3/min、撹拌数
250rpm、温度28℃で40時間処理した後、内容物
を濾紙(No.2)にて吸引濾過、冷水で洗浄後、濾
液5.8にエタノール5.8を加えて沈でんを生成
せしめ、50〜100メツシユのナイロンネツトにて
濾過して得た沈でんを80〜90℃の温水1に溶解
し、冷却後エタノール1を加えて生成した沈で
んを80〜90℃の温水1に加えて20KHz、140W、
1時間の超音波処理のもとに溶解し、これを
3000r.p.m5分で遠心分離して得た分離液全量を凍
結乾燥して白色綿状の多糖1.972gを得た。
この多糖は先に説明した物理、化学的諸性質を
示した。
実施例 2
実施例1において、糖質の処理を終えて濾別し
た湿潤菌糸体を実施例1に示す糖質溶液6を収
容する10容量ジヤーフアーメンターに加え、通
気量3/min、撹拌数250r.p.m温度28℃で69時
間処理した後、内容物を濾紙(No.2)にて吸引濾
過、冷水洗浄後濾液5.9にエタノール5.9加え
て沈でんを生成せしめ、前記同様ナイロンネツト
にて濾過して得た沈でんを80〜90℃の温水1に
溶解し、冷却後エタノール1を加えて生成した
沈でんを80〜90℃の温水0.5に加えて超音波処
理のもとに溶解し、後は実施例1と同様に処理し
て白色綿状の多糖1.595gを得た。ここで得た多
糖も実施例1と同様の性質を示した。
実施例 3
実施例2において、糖質の処理を終えて濾別
し、其の後凍結保存した菌糸体を用い糖質の処理
時間を120時間としたほかは実施例2と同様に処
理して白色綿状の多糖0.830gを得た。
試験例 1
実施例1にて得た多糖について、その薬理作用
について試験した。
IRC―系6週令のマウス(雄、体重27〜30g)
10匹を1群として、同種移植腫瘍サルコーマ180
腫瘍細胞5×106ケをそけい部皮下に移植し、そ
の翌日より生理食塩水に溶解した上記多糖と種々
投与方法及び経路で投与し、移植5週間に腫瘍を
摘出してその重量を測定し、生理食塩水のみを投
与した対照群との比較を行い第2表の結果を得
た。[Table] From Table 1, when the initial PH is set to 2.5 to 6.0, polysaccharide production is observed in all cases, although the amount produced is small, and when the initial PH is set to 3.0 to 4.5, the amount produced is significant. It is recognized that a range of 3.4 to 4.5 is particularly preferable. As mentioned above, this invention does not contain nitrogen sources or inorganic components such as phosphorus, potassium, and magnesium, which are normally essential for culturing microorganisms, and contains only glucose as a carbohydrate, and a small amount of citric acid for pH adjustment. acid and
Since mycelium is added to a carbohydrate solution containing NaOH to produce polysaccharides from glucose,
The production mechanism is clearly different from exopolysaccharide production by culture, and it can be recognized that the mycelium acts enzymatically on glucose used as a carbohydrate. As described above, in this invention, mycelium obtained by culturing bacteria belonging to the genus Sclerotinia is made to act enzymatically on carbohydrates, and various sugars are used as the carbohydrates in addition to the above-mentioned glucose. For example, monosaccharides or trisaccharides such as arabinose, xylose, fructose, mannose, galactose, maltose, sucrose, melibiose, lactose, and raffinose, various oligosaccharides such as fructooligo or galactooligo, starch, dextrin, and gum arabic. and their hydrolysates, other polyhydric alcohols such as glycerin and mannitol, and depending on the use, sweet potato or sugar beet molasses containing sucrose, glucose, fructose, raffinose, etc. However, it is preferable to use glucose, fructose, sucrose, etc. The above-mentioned carbohydrates may be used alone or in combination of two or more. To adjust the initial pH of a carbohydrate solution, citric acid,
Organic acids with strong buffering properties such as tartaric acid and lactic acid are used, but mineral acids such as hydrochloric acid and sulfuric acid as well as buffer solutions can also be used. Furthermore, as shown in Table 1, since the pH decreases over time, the pH may be adjusted with the above-mentioned acids midway through the process to maintain the initial pH. Contact between sugar and mycelium by shaking or stirring
It is carried out for 2 to 8 days in the range of 20 to 30℃, but 28±1℃, 3
±1 day is more preferable. The mycelium of a strain belonging to the genus Sclerotinia may be used immediately after being isolated after culturing, or it may be stored frozen and then thawed each time it is used. Furthermore, the used mycelium that has been used for polysaccharide production can be added to a newly prepared carbohydrate solution and used for polysaccharide production, and although the amount of carbohydrate production will decrease slightly with repeated use, at least the same mycelium can be used for three times.
It can be used for multiple polysaccharide production. Next, in Table 1, the polysaccharide obtained at initial pH 3.5
The results of analysis of the composition and sugar structure of NSG-1 are as follows. (1) Composition analysis, Total sugar Total nitrogen Ash 95% or more Below detection limit Below detection limit However, total sugar content is determined by the phenol sulfuric acid method and is expressed as glucose. (2) As a result of reducing the hydrolyzate of the constituent sugar, trifluoroacetic acid (CF 3 COOH) with sodium borohydride (NaBH 4 ), and analyzing the alditol acetate derivative by gas chromatography, only glucose was clearly identified. , and other sugars such as fucose, xylose, mannose, and galactose are not detected. (3) Binding mode of constituent sugars The results of methylation analysis using the Hakomori method are 2, 3,
4,6-tetramethyl-OD-glycitol:2,4,6-trimethyl-OD-glycitol:2,4-dimethyl-OD-glycitol ratio of 1.0:0.9 to 1.1:0.9 to 1.1 It is known that this glucan has a branch of one 1→6-bonded D-glucopyranosyl residue for every two 1→3-bonded D-glucopyranosyl residues. (4) Smith decomposition products Glucose and glycerin were detected as products by complete Smith decomposition, and glycerin was detected from the external dialysis fluid of the relaxed Smith decomposition product, and only glucose was detected from the hydrolyzed internal fluid. It is known that this glucan has a structure of →3 bonds and a branch at C-6. (5) Infrared absorption spectrum The results measured by the KBr method using a Hitachi 215 model infrared spectrophotometer are shown in Figure 1, with a wave number of 880cm.
Since absorption (P) characteristic of β-glycosidic bond orientation is observed at -1 , it is recognized that it is a β-glycosidic bond structure. (6) 13 C-NMR spectrum The results of dissolving in deuterated dimethyl sulfoxide (DMSC-d 6 ) and measuring with a JEOL-FX200 spectrometer at 60°C are shown in Figure 2.
C included in β (1 → 6) bond in the δ value range of 68 ppm
- Signal S 1 including carbon assignment of 6 and δ value
C-3 included in β (1 → 3) bond in the 86ppm range
Signal S 2 attributed to carbon and δ value 103ppm
The signal S 3 assigned to the C-1 carbon of the β-bond in the region is characteristically recognized, and furthermore, the signal S 2 is
Since it shows two peaks, it is known that the β-glucan structure has two β(1→3) bonds and one β(1→6) bond. From the above study results, this polysaccharide has β-1,3-linked D-glucopyranosyl residues as its main chain and this D
- Recognized as a β-glucan with a branched structure of one β-1,6-linked glucopyranosyl residue for every two glucopyranosyl residues, and exhibits the following properties. (a) Elemental analysis values, etc. C: 42.2-44.0%, H: 5.9-6.2%, N: below the limit of quantification, halogen and sulfur are not quantified. (b) Molecular weight The molecular weight distribution range is 10 6 to 10 7 as determined by gel filtration chromatography using a 0.2 mol NaOH/8 mol urea equilibrium Sepharose CL-4B (Pharmacia Japan) column. (c) Melting point: Blackens and thermally decomposes at approximately 230°C. (d) Specific rotation [α] D at a concentration of 0.1 g/100 ml in water at 20°C
shows 10±5°. (e) Solubility Easily soluble in water, alkali, and dimethyl sulfoxide (DMSO), but insoluble in organic solvents such as ethyl alcohol, methyl alcohol, ether, and acetone. (F) Color reaction Moritsch reaction, Anthrone sulfuric acid reaction, and phenol sulfuric acid reaction are all positive, and both the ninhydrin reaction and Buillet's reaction are negative, which does not indicate the presence of proteins or peptides. (g) Water-soluble basic, acidic, and neutral 1% aqueous solution exhibits a neutral range (PH6 to 6.5). The polysaccharide obtained by the method of this invention has the above-mentioned physical properties,
Since it is a β-glucan with various chemical properties and exhibits antitumor activity as described below, it is useful medicinally, and the manufacturing method itself is extremely simple. Therefore, according to the present invention, antitumor active polysaccharides can be produced at low cost. This polysaccharide can be used for intraperitoneal administration, intravenous administration, intratumoral administration, and oral administration, and can be expected to be used in various other ways. The production method of the present invention and the pharmacological action of the polysaccharide obtained thereby will be specifically explained below. Example 1 Two 5 x 5 x 2 mm sections from the subculture medium of Sclerotinia sclerotiorum IFO9395 were extracted with yeast extract.
25 inoculated into 50 ml of autoclaved medium containing 0.3% polypeptone, 1% polypeptone, and 2% glucose.
C. for 1 week and use this as a primary inoculum.
Then autoclaved medium with the same composition as above
Inoculate 5 ml of the primary inoculum into 100 ml, culture with shaking at 25°C for 4 days, and use this as the secondary inoculum.Next, take medium 6 with the same composition as above into a 10-volume jar fermenter, and inoculate it with the above secondary inoculum. Add two bottles (200 ml) of the inoculum and culture at 28°C for 3 days with an aeration rate of 3/min.
423.2 mg of culture was obtained. The entire content was suction filtered through filter paper (No. 2), thoroughly washed with water, water was removed, and the entire amount was mixed with 5% glucose, citric acid, and
Add to carbohydrate solution 6 containing 0.5% and adjusted to pH 3.5 with 5N-NaOH, aeration rate 3/min, stirring number
After processing for 40 hours at 250 rpm and a temperature of 28°C, the contents were suction filtered using filter paper (No. 2), washed with cold water, and ethanol 5.8 was added to the filtrate to form a precipitate. Dissolve the precipitate obtained by filtration with a net in 1 part of warm water at 80 to 90°C, and after cooling, add 1 part to ethanol. Add the resulting precipitate to 1 part of hot water at 80 to 90°C, and heat at 20KHz, 140W,
Dissolved under ultrasonication for 1 hour.
The entire amount of the separated liquid obtained by centrifugation at 3000 rpm for 5 minutes was freeze-dried to obtain 1.972 g of white cotton-like polysaccharide. This polysaccharide exhibited the physical and chemical properties described above. Example 2 In Example 1, the wet mycelium that had been filtered after the sugar treatment was added to a 10-capacity jar fermenter containing the sugar solution 6 shown in Example 1, and the mixture was stirred at an aeration rate of 3/min. After processing at several 250 rpm for 69 hours at a temperature of 28°C, the contents were suction filtered using filter paper (No. 2), washed with cold water, 5.9% of ethanol was added to 5.9% of the filtrate to form a precipitate, and filtered using a nylon net as above. The precipitate obtained was dissolved in 1 part of warm water at 80 to 90°C, and after cooling, 1 part of ethanol was added. It was treated in the same manner as in Example 1 to obtain 1.595 g of white flocculent polysaccharide. The polysaccharide obtained here also showed the same properties as in Example 1. Example 3 The cells were treated in the same manner as in Example 2, except that the mycelium was filtered after the carbohydrate treatment and then frozen and preserved, and the carbohydrate treatment time was changed to 120 hours. 0.830 g of white flocculent polysaccharide was obtained. Test Example 1 The polysaccharide obtained in Example 1 was tested for its pharmacological action. IRC-strain 6-week-old mouse (male, weight 27-30g)
Allograft tumor sarcoma 180 in groups of 10 animals
5 x 10 6 tumor cells were transplanted subcutaneously in the groin area, and from the next day, the above polysaccharide dissolved in physiological saline was administered by various administration methods and routes, and 5 weeks after transplantation, the tumor was removed and its weight was measured. A comparison was made with a control group to which only physiological saline was administered, and the results shown in Table 2 were obtained.
【表】【table】
【表】
第2表から判明する如く、いずれの投与経路に
よつても高い抑止効果が認められ、特に経口投与
により50%以上の抑止率を認めたことはこの発明
の多糖の大きな特徴である。
試験例 2
実施例1にて得た多糖について同系移植腫瘍
Meth A繊維肉腫及び乳ガンMM46に対する活性
を試験した結果第3表の如くで同系腫瘍に対して
も抗腫瘍活性を認めた。[Table] As is clear from Table 2, the polysaccharide of this invention has a high inhibitory effect by any route of administration, and in particular, the inhibition rate of 50% or more was observed by oral administration, which is a major feature of the polysaccharide of this invention. . Test Example 2 Syngeneic transplantation of the polysaccharide obtained in Example 1
As a result of testing the activity against Meth A fibrosarcoma and breast cancer MM46, as shown in Table 3, antitumor activity was also observed against syngeneic tumors.
【表】
(発明の効果)
この発明の方法によるときは、煩雑な精製手段
を用いることなくきわめて容易に純良な製品とし
て収得できるので安価に量産をもたらし、収得し
た多糖は各種腫瘍に対し抗腫瘍活性を示し、使用
に当つては注射による投与のほか経口による投与
も可能とするもので、各種剤形で使用でき薬剤と
してきわめて有用である。[Table] (Effects of the invention) When the method of this invention is used, it is possible to obtain a pure product very easily without using complicated purification means, resulting in mass production at low cost, and the obtained polysaccharide has antitumor effects against various tumors. It exhibits activity and can be administered orally in addition to injection, and can be used in various dosage forms and is extremely useful as a drug.
第1図はこの発明の多糖の赤外線吸収スペクト
ルを示し、第2図は同多糖のジメチルスルフオキ
シド中における 13C―NMRスペクトルを示す。
FIG. 1 shows the infrared absorption spectrum of the polysaccharide of the present invention, and FIG. 2 shows the 13 C-NMR spectrum of the same polysaccharide in dimethyl sulfoxide.
Claims (1)
下記物理化学的性質を有し、β―1,3結合のD
―グルコピラノシル残基を主鎖としこのD―グル
コピラノシル残基2ケごとにβ―1,6結合のグ
ルコピラノシル残基1ケを分枝構造として持つ多
糖NSG―1生産菌株を培養し、得られた培養菌
体を、糖質含有溶液中でインキユベーシヨンし、
多糖NSG―1を生成せしめ、反応液から多糖
NSG―1を採取することを特徴とする多糖NSG
―1の製造方法。 (1) 赤外線吸収スペクトル(KBr法) 波数880cm-1にβ―グリコシド結合配向に特
徴的な吸収(P)がある。 (2) 13C―NMRスペクトル(DMSO―d6中) δ値68ppm域のβ(1→6)結合に含まれる
C―6の炭素の帰属を含むシグナルS1、δ値
86ppm域のβ(1→3)結合に含まれるC―3
の炭素に帰属する2ケのピークを示すシグナル
S2、δ値103ppm域のβ結合のC―1の炭素に
帰属するシグナルS3の特徴的なシグナルがあ
る。 (3) 元素分析値:C42.2〜44.0%、H5.9〜6.2%、
N定量限界以下。 (4) 分子量(ゲル濾過法):106〜107範囲。 (5) 融点 約230℃で黒色化熱分解。 (6) 比旋光度:〔α〕D10±5゜(C=0.1,H2O)。 (7) 溶解性:水、アルカリ、ジメチルスルフオキ
シドに易溶。エチルアルコール、メチルアルコ
ール、エーテル、アセトン等の有機溶剤に不
溶。 (8) 呈色反応:モーリツシユ反応、アンスロン硫
酸反応、フエノール硫酸反応が陽性。ニンヒド
リン反応、ビユーレツト反応が陰性。 (9) 水溶液の塩基性、酸性、中性の別 1%水溶液は中性域(PH6〜6.5)を示す。 2 多糖NSG―1生産菌株がスクレロチニア
スクレロチオリウム(Sclerotinia sclerotiorum)
IFO 9395である特許請求の範囲第1項記載の多
糖NSG―1の製造方法。[Scope of Claims] 1. Belongs to the genus Sclerotinia and has the following physicochemical properties, and has a β-1,3 bond D
- Cultivate a polysaccharide NSG-1 producing strain that has glucopyranosyl residues as a main chain and one β-1,6-linked glucopyranosyl residue as a branched structure for every two D-glucopyranosyl residues, and the resulting culture. Incubating the bacterial cells in a carbohydrate-containing solution,
Polysaccharide NSG-1 is produced, and polysaccharide is extracted from the reaction solution.
Polysaccharide NSG characterized by collecting NSG-1
-1 manufacturing method. (1) Infrared absorption spectrum (KBr method) There is an absorption (P) characteristic of β-glycosidic bond orientation at a wave number of 880 cm -1 . (2) 13 C-NMR spectrum (in DMSO-d 6 ) Signal S 1 including the assignment of C-6 carbon included in the β (1 → 6) bond in the δ value range of 68 ppm, δ value
C-3 included in β (1 → 3) bond in the 86ppm range
A signal showing two peaks attributed to the carbon of
There is a characteristic signal of S 2 and a signal S 3 attributed to the C-1 carbon of the β bond with a δ value in the 103 ppm range. (3) Elemental analysis values: C42.2-44.0%, H5.9-6.2%,
Below the N quantification limit. (4) Molecular weight (gel filtration method): 10 6 to 10 7 range. (5) Blackening thermal decomposition at melting point of approximately 230℃. (6) Specific rotation: [α] D 10±5° (C=0.1, H 2 O). (7) Solubility: Easily soluble in water, alkali, and dimethyl sulfoxide. Insoluble in organic solvents such as ethyl alcohol, methyl alcohol, ether, and acetone. (8) Color reaction: Moritsch reaction, Anthrone sulfuric acid reaction, and phenol sulfuric acid reaction are positive. Ninhydrin reaction and Biuretz reaction were negative. (9) Basic, acidic, and neutral aqueous solutions A 1% aqueous solution exhibits a neutral range (PH6 to 6.5). 2 The polysaccharide NSG-1 producing strain is Sclerotinia
Sclerotinia sclerotiorum
A method for producing polysaccharide NSG-1 according to claim 1, which is IFO 9395.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP30522286A JPH0236235B2 (en) | 1986-12-23 | 1986-12-23 | TATONSGG1NOSEIZOHOHO |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP30522286A JPH0236235B2 (en) | 1986-12-23 | 1986-12-23 | TATONSGG1NOSEIZOHOHO |
Publications (2)
Publication Number | Publication Date |
---|---|
JPS63157994A JPS63157994A (en) | 1988-06-30 |
JPH0236235B2 true JPH0236235B2 (en) | 1990-08-16 |
Family
ID=17942510
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP30522286A Expired - Lifetime JPH0236235B2 (en) | 1986-12-23 | 1986-12-23 | TATONSGG1NOSEIZOHOHO |
Country Status (1)
Country | Link |
---|---|
JP (1) | JPH0236235B2 (en) |
-
1986
- 1986-12-23 JP JP30522286A patent/JPH0236235B2/en not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
JPS63157994A (en) | 1988-06-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US4225673A (en) | Method of preparing glucan having antitumor activity | |
JPH03503238A (en) | Enzymatic synthesis method of oligodextran useful for producing sugar substitutes and novel oligodextran | |
CN111978421B (en) | Phellinus igniarius polysaccharide and preparation and application thereof | |
CH634855A5 (en) | PROCESS FOR THE PRODUCTION OF NEW BETA-1,3-GLUCAN DERIVATIVES. | |
US5424201A (en) | Method for preparing an antitumor dextran using Lactobacillus confusus | |
US4614733A (en) | Polysaccharides pharmaceutical compositions and the use thereof | |
JPH0248161B2 (en) | ||
Manzoni et al. | Production and purification of an extracellularly produced K4 polysaccharide from Escherichia coli | |
JPH0372084B2 (en) | ||
JPH0236235B2 (en) | TATONSGG1NOSEIZOHOHO | |
JPS62228293A (en) | Production of inulooligosaccharide | |
JPH025763B2 (en) | ||
JPS603319B2 (en) | amino sugar derivative | |
JPS6359679B2 (en) | ||
JPS62130695A (en) | Production of galactooligo saccharide | |
WO1990010010A1 (en) | New substance trehalostatin and production thereof | |
JP3075443B2 (en) | Method for producing laminari-oligosaccharide | |
JPS5836395A (en) | Preparation of polysaccharide | |
JP3656762B2 (en) | Manufacturing method of laminari triose | |
JPS62208277A (en) | Production of inulinase | |
JPH11155564A (en) | Production of beta-dfa and enzyme for use | |
JPS6147518B2 (en) | ||
JPS6147519B2 (en) | ||
JP2887689B2 (en) | Method for producing glycyrrhetinic acid monoglucuronide | |
JPS5922517B2 (en) | Method for producing antitumor polysaccharide C↓-45 |